These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36380025)

  • 1. New IDEAS about amyloid, race and dementia disparities.
    Dark HE; Walker KA
    Nat Rev Neurol; 2023 Jan; 19(1):5-6. PubMed ID: 36380025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midlife blood pressure, amyloid-β, and risk for Alzheimer disease: one more reason to treat hypertension.
    Elias MF; Davey A
    Hypertension; 2012 Apr; 59(4):771-2. PubMed ID: 22392898
    [No Abstract]   [Full Text] [Related]  

  • 3. Dementia: a problem for our age.
    Abbott A
    Nature; 2011 Jul; 475(7355):S2-4. PubMed ID: 21760579
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study.
    Sundelöf J; Giedraitis V; Irizarry MC; Sundström J; Ingelsson E; Rönnemaa E; Arnlöv J; Gunnarsson MD; Hyman BT; Basun H; Ingelsson M; Lannfelt L; Kilander L
    Arch Neurol; 2008 Feb; 65(2):256-63. PubMed ID: 18268197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Economic Assessment in Early-Stage Dementia by Severity and Amyloid-β Status: A 5-Year Retrospective Claims Study of GERAS-US Patients.
    Chandler J; Kubisiak J
    J Alzheimers Dis; 2023; 91(2):753-765. PubMed ID: 36502319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head injury and dementia.
    Jellinger KA
    Curr Opin Neurol; 2004 Dec; 17(6):719-23. PubMed ID: 15542981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Racial Disparities in Biomarkers for Alzheimer Disease.
    Morris JC; Schindler SE; McCue LM; Moulder KL; Benzinger TLS; Cruchaga C; Fagan AM; Grant E; Gordon BA; Holtzman DM; Xiong C
    JAMA Neurol; 2019 Mar; 76(3):264-273. PubMed ID: 30615028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia.
    Mc Donald JM; Savva GM; Brayne C; Welzel AT; Forster G; Shankar GM; Selkoe DJ; Ince PG; Walsh DM;
    Brain; 2010 May; 133(Pt 5):1328-41. PubMed ID: 20403962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
    Jansen WJ; Janssen O; Tijms BM; Vos SJB; Ossenkoppele R; Visser PJ; ; Aarsland D; Alcolea D; Altomare D; von Arnim C; Baiardi S; Baldeiras I; Barthel H; Bateman RJ; Van Berckel B; Binette AP; Blennow K; Boada M; Boecker H; Bottlaender M; den Braber A; Brooks DJ; Van Buchem MA; Camus V; Carill JM; Cerman J; Chen K; Chételat G; Chipi E; Cohen AD; Daniels A; Delarue M; Didic M; Drzezga A; Dubois B; Eckerström M; Ekblad LL; Engelborghs S; Epelbaum S; Fagan AM; Fan Y; Fladby T; Fleisher AS; Van der Flier WM; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Frings L; Frisoni GB; Fröhlich L; Gabryelewicz T; Gertz HJ; Gill KD; Gkatzima O; Gómez-Tortosa E; Grimmer T; Guedj E; Habeck CG; Hampel H; Handels R; Hansson O; Hausner L; Hellwig S; Heneka MT; Herukka SK; Hildebrandt H; Hodges J; Hort J; Huang CC; Iriondo AJ; Itoh Y; Ivanoiu A; Jagust WJ; Jessen F; Johannsen P; Johnson KA; Kandimalla R; Kapaki EN; Kern S; Kilander L; Klimkowicz-Mrowiec A; Klunk WE; Koglin N; Kornhuber J; Kramberger MG; Kuo HC; Van Laere K; Landau SM; Landeau B; Lee DY; de Leon M; Leyton CE; Lin KJ; Lleó A; Löwenmark M; Madsen K; Maier W; Marcusson J; Marquié M; Martinez-Lage P; Maserejian N; Mattsson N; de Mendonça A; Meyer PT; Miller BL; Minatani S; Mintun MA; Mok VCT; Molinuevo JL; Morbelli SD; Morris JC; Mroczko B; Na DL; Newberg A; Nobili F; Nordberg A; Olde Rikkert MGM; de Oliveira CR; Olivieri P; Orellana A; Paraskevas G; Parchi P; Pardini M; Parnetti L; Peters O; Poirier J; Popp J; Prabhakar S; Rabinovici GD; Ramakers IH; Rami L; Reiman EM; Rinne JO; Rodrigue KM; Rodríguez-Rodriguez E; Roe CM; Rosa-Neto P; Rosen HJ; Rot U; Rowe CC; Rüther E; Ruiz A; Sabri O; Sakhardande J; Sánchez-Juan P; Sando SB; Santana I; Sarazin M; Scheltens P; Schröder J; Selnes P; Seo SW; Silva D; Skoog I; Snyder PJ; Soininen H; Sollberger M; Sperling RA; Spiru L; Stern Y; Stomrud E; Takeda A; Teichmann M; Teunissen CE; Thompson LI; Tomassen J; Tsolaki M; Vandenberghe R; Verbeek MM; Verhey FRJ; Villemagne V; Villeneuve S; Vogelgsang J; Waldemar G; Wallin A; Wallin ÅK; Wiltfang J; Wolk DA; Yen TC; Zboch M; Zetterberg H
    JAMA Neurol; 2022 Mar; 79(3):228-243. PubMed ID: 35099509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging of Alzheimer disease pathology.
    Kantarci K
    AJNR Am J Neuroradiol; 2014 Jun; 35(6 Suppl):S12-7. PubMed ID: 24503555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Alzheimer disease research highlights: evidence for novel risk factors.
    Brenowitz WD; Xiang Y; McEvoy CT; Yang C; Yaffe K; Le WD; Leng Y
    Chin Med J (Engl); 2021 Sep; 134(18):2150-2159. PubMed ID: 34507318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.
    Andreasen N; Hesse C; Davidsson P; Minthon L; Wallin A; Winblad B; Vanderstichele H; Vanmechelen E; Blennow K
    Arch Neurol; 1999 Jun; 56(6):673-80. PubMed ID: 10369305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of dementia screening tests with biomarkers of Alzheimer's disease.
    Galvin JE; Fagan AM; Holtzman DM; Mintun MA; Morris JC
    Brain; 2010 Nov; 133(11):3290-300. PubMed ID: 20823087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
    Mullane K; Williams M
    Biochem Pharmacol; 2020 Jul; 177():113945. PubMed ID: 32247851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Between Multimorbidity and Cerebrospinal Fluid Amyloid: A Cross-Sectional Analysis of the European Prevention of Alzheimer's Dementia (EPAD) V500.0 Cohort.
    Stirland LE; Russ TC; Ritchie CW; Muniz-Terrera G;
    J Alzheimers Dis; 2019; 71(2):703-711. PubMed ID: 31424394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder.
    Butterfield DA; Sultana R
    J Alzheimers Dis; 2007 Aug; 12(1):61-72. PubMed ID: 17851195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies.
    Smith C; Malek N; Grosset K; Cullen B; Gentleman S; Grosset DG
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1234-1243. PubMed ID: 31444276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer disease: Alzheimer dementia with sparse amyloid-AD mimic or variant?
    Serrano-Pozo A; Hyman BT
    Nat Rev Neurol; 2015 Dec; 11(12):674-5. PubMed ID: 26553593
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain Amyloid Pathology and Cognitive Function: Alzheimer Disease Without Dementia?
    Visser PJ; Tijms B
    JAMA; 2017 Jun; 317(22):2285-2287. PubMed ID: 28609518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.